首页>
外国专利>
Improvement of sexual arousal, sexual desire, orgasm, and / or pleasure following intravaginal prasterone (DHEA) administration in women who do not have or are independent of dyspareunia or other symptoms of vulvar vaginal atrophy.
Improvement of sexual arousal, sexual desire, orgasm, and / or pleasure following intravaginal prasterone (DHEA) administration in women who do not have or are independent of dyspareunia or other symptoms of vulvar vaginal atrophy.
To treat sexual arousal, sexual desire and/or orgasm problems in women not suffering from dyspareunia or symptoms of vulvovaginal atrophy and also in premenopausal women having no symptoms/signs of vaginal atrophy.SOLUTION: Intravaginal DHEA is used for treatment of at least one condition selected from the group consisting of female hypoactive sexual desire disorder, female sexual arousal disorder, female orgasm disorder and female sexual interest arousal disorder in a woman who either (1) is not suffering from symptoms of vulvo-vaginal atrophy and/or (2) is not suffering from moderate to severe dyspareunia.SELECTED DRAWING: Figure 1
展开▼
